MEP of the week

Lobby organisation

AbbVie

Business / industry · Health & pharma · HQ: United States · Transparency Register entry

As of 9 September 2026, AbbVie appears in 66 declared MEP meetings (41 different MEPs), most often with European People's Party.

66
declared meetings
with current MEPs
41
MEPs met
€1.0M/yr
declared lobbying spend
self-reported to the register
2.5
lobbyists
full time equivalent

In their own words

“AbbVie is a Specialty-focused, research-based biopharmaceutical company focused on developing new products and new ways to help people manage some of the most serious health conditions. We are scientists, researchers, communicators, manufacturing specialists, and regulatory experts. AbbVie began as the pharmaceutical leader, Abbott, which was founded in 1888 by Chicago physician, Dr. Wallace Abbott. Since then, Abbott has evolved to…”

Stated goals from the organisation's own Transparency Register filing.

Who they meet, and when

Which groups they meet

Share of this organisation's 66 declared meetings, by the meeting MEP's political group.

European People's Party2944%
Socialists & Democrats1726%
Renew Europe914%
European Conservatives & Reformists69%
Patriots for Europe35%
Greens/EFA23%

Meetings by year

Declared meetings per calendar year, 2022–2026. Bar length is relative to its busiest year (27 in 2025).

2022
5
2023
10
2024
9
2025
27
2026
15

Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.

The MEPs they meet most

Tomislav Sokol
5 meetings · EPP
Nicolás González Casares
4 meetings · S&D
Tiemo Wölken
3 meetings · S&D
Andreas Glück
3 meetings · Renew
Pascal Arimont
3 meetings · EPP

The 15 most recent declared meetings

DateMEPSubject
29 Jun 2026Eleonora MeletiWOMEN'S HEALTH
25 Jun 2026Ingeborg ter LaakBiotech Act
4 Jun 2026Aurelijus VerygaStrengthening Europe's Biotech Ecosystem
1 Jun 2026Maria Grapinihealthcare
1 Jun 2026Gabriela FireaMeeting on EU health policy
1 Jun 2026Gabriela FireaHealth at a Crossroads: Active Aging, Prevention & Demographic Resilience
7 May 2026Wouter BekeEU Biotech Act I
28 Apr 2026Ingeborg ter LaakBiotech Act
9 Apr 2026Aurelijus VerygaFollow-Up Discussion on the Critical Medicines Act
9 Apr 2026Margarita de la Pisa CarriónSANT COMMITTEE ONGOING WORK
25 Mar 2026Tomislav SokolHealth policy
17 Mar 2026Tomislav SokolHealth policy
13 Mar 2026Nicolás González CasaresBiotech
19 Feb 2026Elena Nevado del CampoInnovación sanitaria en Europa
6 Jan 2026Jutta PaulusStandortbesuch

Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.